medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Predictive accuracy of computer-aided versions of the on-admission
National Early Warning Score in estimating the risk of COVID-19 for
unplanned admission to hospital: a retrospective development and
validation study
Authors

Muhammad Faisal, PhD
Senior Research Fellow in Biostatistics
Faculty of Health Studies, University of Bradford, Bradford, UK
Bradford Institute for Health Research Bradford, UK
NIHR Yorkshire and Humber Patient Safety Translational Research Centre (YHPSTRC), Bradford, UK
Wolfson Centre for Applied Health Research, Bradford, UK
E-mail: M.Faisal1@bradford.ac.uk
Mohammed A Mohammed, PhD
Professor of Healthcare Quality & Effectiveness
Faculty of Health Studies, University of Bradford, Bradford, UK
NHS Midlands and Lancashire Commissioning Support Unit,
The Strategy Unit,
Kingston House,
West Bromwich, B70 9LD, UK
E-mail: M.A.Mohammed5@Bradford.ac.uk
Donald Richardson, FRCP
Deputy Medical Director , Chief Clinical Information Officer, Consultant Renal Physician
Department of Renal Medicine, York Teaching Hospitals NHS Foundation Trust
E-mail: drichardson@doctors.org.uk
Ewout W. Steyerberg, PhD
Professor of Medical Decision Making,
Department of Public Health, Erasmus University, Rotterdam, The Netherlands
Leiden University Medical Center Leiden, The Netherlands
E-mail: E.Steyerberg@ErasmusMC.nl
Massimo Fiori
Senior Analyst/ Programmer
York Teaching Hospitals NHS Foundation Trust, England UK
E-mail: massimo.fiori@york.nhs.uk
Kevin Beatson, MSc
Head of Systems Development
York Teaching Hospitals NHS Foundation Trust, England UK
E-mail: Kevin.Beatson@York.NHS.uk
Correspondence to: M A Mohammed

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Abstract

Objectives: To consider the potential of the National Early Warning Score (NEWS2) for COVID-19 risk

prediction on unplanned admission to hospital.
Design: Logistic regression model development and validation study using a cohort of unplanned
emergency medical admission to hospital.
Setting: York Hospital (YH) as model development dataset and Scarborough Hospital (SH) as model
validation dataset.
Participants: Unplanned adult medical admissions discharged over 3 months (11 March 2020 to 13
June 2020 ) from two hospitals (YH for model development; SH for external model validation) based
on admission NEWS2 electronically recorded within Â±24 hours of admission. We used logistic
regression modelling to predict the risk of COVID-19 using NEWS2 (Model M0â€™) versus enhanced
cNEWS models which included age + sex (model M1â€™) + subcomponents (including diastolic blood
pressure + oxygen flow rate + oxygen scale) of NEWS2 (model M2â€™). The ICD-10 code â€˜U071â€™ was
used to identify COVID-19 admissions. Model performance was evaluated according to
discrimination (c statistic), calibration (graphically), and clinical usefulness at NEWS2 â‰¥5.
Results The prevalence of COVID-19 was higher in SH (11.0%=277/2520) than YH (8.7%=343/3924)
with higher index NEWS2 (3.2 vs 2.8) but similar in-hospital mortality (8.4% vs 8.2%). The c-statistics
for predicting COVID-19 for cNEWS models (M1â€™,M2â€™) was substantially better than NEWS2 alone
(M0â€™) in development (M2â€™: 0.78 (95%CI 0.75-0.80) vs M0â€™ 0.71 (95%CI 0.68-0.74)) and validation
datasets (M2â€™: 0.72 (95%CI 0.69-0.75) vs M0â€™ 0.65 (95%CI 0.61-0.68)). Model M2â€™ had better
calibration than Model M0â€™ with improved sensitivity (M2â€™: 57% (95%CI 51%-63%) vs M0â€™ 44%
(95%CI 38%-50%)) and similar specificity (M2â€™: 76% (95%CI 74%-78%) vs M0â€™ 75% (95%CI 73%-77%))
for validation dataset at NEWS2â‰¥5.
Conclusions Model M2â€™ is reasonably accurate for predicting the on-admission risk of COVID-19. It
may be clinically useful for an early warning system at the time of admission especially to triage
large numbers of unplanned hospital admissions.
Keywords: vital signs, national early warning score, emergency admission, novel coronavirus SARS-

19, computer-aided national early warning score

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Introduction

The novel coronavirus SARS-19 produces the newly identified disease â€˜COVID-19â€™ in patients with
symptoms (Coronaviridae Study Group of the International Committee on Taxonomy of Viruses(1))
which was declared as a pandemic on 11-March-2020 that has challenged health care systems
worldwide.
COVID-19 patients admitted to hospital can develop severe disease with life threatening respiratory
and/or multi-organ failure (2, 3) with a high risk of mortality in part due to the lack of an effective
treatment (bar supportive care) for the underlying disease. The appropriate early assessment and
management of patients with COVID-19 is important in ensuring high-quality care including isolation,
escalation to critical care or palliative care. Early assessment of the risk of COVID-19 is crucial to this
process. Presently this involves clinical judgment based on the patients presenting history, signs and
symptoms and viral nucleic acid testing can have a 24-hour turnaround time (4).
We posit that vital signs, which form the basis of Early Waning Scores (EWS) may be useful in
supporting the clinical decision-making process before swab test results are available. EWS, which
are widely used in hospitals worldwide, and in the National Health Service (NHS) hospitals in
England, the patientâ€™s vital signs are monitored and summarised into a National Early Warning Score
(NEWS)(5). NEWS offers a standardised approach to assessing acute illness and is derived from seven
physiological variables or vital signs â€“ respiration rate, oxygen saturations, any supplemental oxygen,
temperature, systolic blood pressure, heart rate and level of consciousness (Alert (A), Voice (V), Pain
(P), Unresponsive (U)) â€“ which are routinely collected by nursing staff as an integral part of the
process of care.
NEWS was launched by the Royal College of Physicians in 2012 (5) and has gained widespread
interest from across the world, including Europe, India, the USA (and the US Navy)(6). In December
2017, an update to NEWS (NEWS2) was published (6) that extends the level of consciousness from
AVPU to ACVPU, where C represents new confusion or delirium and is allocated 3 points (the
maximum for a single variable). NEWS2 also offers two scales for oxygen saturation (scale 1 and
scale 2) which accommodates patients with hypercapnic respiratory failure who have clinically
recommended oxygen saturation of 88â€“92%.
Whilst hospitals continue to use NEWS2 during the COVID-19 pandemic, we determine the extent to
which NEWS2 can be used predict the risk of COVID-19 by computer enhanced NEWS2 models. This
approach is clinically useful because it places no additional data collection burden on staff whilst
having the potential of providing an early indication of COVID-19 risk before findings of a swab test
are reported - thus supporting early triage of COVID-19 and non-COVID-19 patients.

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Methods
Setting & data

Our cohorts of emergency medical admissions are from two acute hospitals which are approximately
65 kilometres apart in the Yorkshire & Humberside region of England â€“ Scarborough hospital (n~300
beds) and York Hospital (YH) (n~700 beds), managed by York Teaching Hospitals NHS Foundation
Trust. We selected these hospitals because they had electronic NEWS2, which are collected as part
of the patientâ€™s process of care and were agreeable to the study. Since NEWS2 extends NEWS, we
use the same dataset to develop and validate NEWS and NEWS2 models, especially as NEWS is still in
widespread use.
We considered all consecutive adult (ageâ‰¥18 years) non-elective or emergency medical admissions
discharged during 3 months (11 March 2020 to 13 June 2020), with electronic NEWS2. For each
emergency admission, we obtained a pseudonymised patient identifier, patientâ€™s age (years), gender
(male/female), discharge status (alive/dead), admission and discharge date and time, diagnoses
codes based on the 10th revision of the International Statistical Classification of Diseases (ICD-10),
NEWS2 (including its subcomponents respiratory rate, temperature, systolic pressure, pulse rate,
oxygen saturation, oxygen supplementation, oxygen scales 1 & 2, and alertness including confusion).
The diastolic blood pressure was recorded at the same time as systolic blood pressure. Historically,
diastolic blood pressure has always been a routinely collected physiological variable on vital sign
charts and is still collected where electronic observations are in place. NEWS2 produces integer
values that range from 0 (indicating the lowest severity of illness) to 20 (the maximum NEWS2 value
possible) (see Table S1 and S2 in supplementary material). The index NEWS2 was defined as the first
electronically recorded NEWS2 within Â±24 hours of the admission time. We excluded records where
the index NEWS2 was not within Â±24 hours or was missing/not recorded at all (see Table 1). The ICD10 code â€˜U071â€™ was used to identify records with COVID-19. We searched primary and secondary
ICD-10 codes for â€˜U071â€™ for identifying COVID-19.
Statistical Modelling

We began with exploratory analyses including box plots that showed the relationship between
covariates and risk of COVID-19 and line plots showed the relationship between age, vital signs,
NEWS2 and risk of COVID-19. We developed three logistic regression models for each NEWS and
NEWS2 separately predicting the risk of COVID-19. The NEWS models (M0, M1, M2) use the index or
first recorded NEWS within Â±24hours of admission. Model M0 uses NEWS alone; Model M1 extends
M0 with age and sex and Model M2 extends M1 with all the subcomponents of NEWS plus diastolic

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

blood pressure. Equivalent models (M0â€™, M1â€™, M2â€™) using NEWS2 were also developed but they
include oxygen flow rate as a continuous covariate and scale 1/scale 2 as a binary covariate.
We used the qladder function (Stata (7)), which displays the quantiles of a transformed variable
against the quantiles of a normal distribution according to the ladder powers
for each continuous covariate and chose the following
 à¬· ,  à¬¶ ,  à¬µ , , âˆš, log ,  à¬¿à¬µ ,  à¬¿à¬¶ ,  à¬¿à¬·
transformations:- log (respiratory rate), log (pulse rate), log (systolic blood pressure), and log
(diastolic blood pressure).
We developed all models using York Hospital (YH) data (as development dataset) and externally
validated their performance on Scarborough Hospital (SH) data (as validation dataset). The hospitals
are part of the same NHS Trust but are geographically separated by about 65 kilometres (40 miles).
We report discrimination and calibration statistics as performance measures for these models (8).
Discrimination relates to how well a model can separate, (or discriminate) between admissions with
and without COVID-19 and is given by the area under the Receiver Operating Characteristics (ROC)
curve (AUC) or c-statistic. The ROC curve is a plot of the sensitivity, (true positive rate), versus 1specificity, (false positive rate), for consecutive predicted risks. A c-statistic of 0.5 is no better than
tossing a coin, whilst a perfect model has a c-statistic of 1. In general, values less than 0.7 are
considered to show poor discrimination, values of 0.7 to 0.8 can be described as reasonable, and
values above 0.8 suggest good discrimination (9). The 95% confidence interval for the c-statistic was
derived using DeLongâ€™s method as implemented in the pROC library (10) in R (11).
Calibration is the relationship between the observed and predicted risk of COVID-19 (24) and can be
readily seen on a scatter plot (y-axis observed risk, x-axis predicted risk). Perfect predictions should
be on the 45Â° line. We internally validated and assessed the calibration for all the models using the
bootstrapping approach (12, 13). The overall statistical performance was assessed using the scaled
Brier score which incorporates both discrimination and calibration (8). The Brier score is the squared
difference between actual outcomes and predicted risk of COVID-19, scaled by the maximum Brier
score such that the scaled Brier score ranges from 0â€“100%. Higher values indicate superior models.
The cut-off of NEWS2 is 5 or more. This is the recommended threshold for detecting deteriorating
patients and sepsis (14, 15). Therefore, we assessed the sensitivity, specificity, positive and negative
predictive values and likelihood ratios for these models at NEWS2 threshold of 5+ (16). We further
compared the Net Benefit for all these NEWS and NEWS2 models, which may inform the utility of
the models in routine clinical practice (17). The net benefit is calculated at a particular threshold
probability à¯§ with total sample size as follows:
e

e

e

e

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

    



 





 



à¯§

1 à¯§

The highest net benefit has the highest clinical value.
We calculated the minimum sample size using the R package pmsampsize (18). We found 930 (93
events) is minimum required sample size with number of predictors =21, R2=0.182, prevalence
=0.10, shrinkage>0.9, margin absolute prediction error (MAPE) = 0.05 (19). We followed the TRIPOD
guidelines for reporting of model development and validation (20). We used Stata (7) for data
cleaning and R (11) for statistical analysis.
Results
Cohort Characteristics

The number of non-elective discharges was 6444 over 3 months. We excluded 36 (0.6%) of
admissions because the index NEWS was not recorded within Â±24 hours of the admission date/time
or there was missing or no recorded at all (see Table S3).
The characteristics of the admissions included in our study are shown in Table 1. Emergency
admissions in the validation dataset were older than those in development dataset (69.6 years vs
67.4 years), less likely to be male (49.5% vs 51.2%), had higher index NEWS (2.8 vs 2.5) and NEWS2
(3.2 vs 2.8), higher prevalence of COVID-19 (11.0% vs 8.7%) but similar in-hospital mortality (8.4% vs
8.2%). See accompanying scatter and boxplots in Figure S1 to S4 â€“ supplemental digital content.

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Characteristic

N
Male (%)
Mean Age [years] (SD)
Median Length of Stay (days) (IQR)
COVID-19 (%)
Mortality
Mortality with-in 24 hours (%)
Mortality with-in 48 hours (%)
Mortality with-in 72 hours (%)
In-hospital Mortality
Mean NEWS (SD)
Mean NEWS2 (SD)
Vital Signs
Mean Respiratory rate [breaths per
minute] (SD)
Mean Temperature [ C] (SD)
Mean Systolic pressure [mmHg] (SD)
Mean Diastolic pressure [mmHg] (SD)
Mean Pulse rate [beats per minute]
(SD)
Mean Oxygen saturation (SD)
Oxygen supplementation (%)
Mean oxygen flow rate (units) (SD)
Oxygen scale 2 (yes) (%)
Alertness
Alert (%)
Baseline confusion (%)
New confusion (%)
Pain (%)
Voice (%)
Unconscious (%)
o

Development
dataset (YH)

3924
2010 (51.2)
67.4 (18.7)
3.0 (5.8)
343 (8.7)
30 (0.8)
61 (1.6)
96 (2.4)
323 (8.2)
2.5 (2.3)
2.8 (2.8)
19.8 (5.1)
36.4 (0.9)
141.8 (29.2)
79.2 (16.5)
89.1 (22.3)
96.3 (3.1)
512 (13)
7.1 (5.7)
240 (6.1)
3510 (89.4)
27 (0.7)
61 (1.6)
32 (0.8)
151 (3.8)
143 (3.6)

Validation
dataset (SH)

2520
1247 (49.5)
69.6 (18.9)
3.7 (6.1)
277 (11.0)
32 (1.3)
48 (1.9)
68 (2.7)
212 (8.4)
2.8 (2.4)
3.2 (2.8)
20.7 (5.6)
36.3 (1)
142 (28.5)
79 (17.3)
88.5 (22.1)
96.1 (3.2)
362 (14.4)
6.1 (5.3)
163 (6.5)
2243 (89)
23 (0.9)
40 (1.6)
17 (0.7)
134 (5.3)
63 (2.5)

Degree of
freedom
(df)

1
5320
1
1
1
1
1
5201
5446
5027
4817
5455
5193
5406
5182
1
811
1
5

p-value

0.181
<0.001
<0.001
0.003
0.058
0.335
0.585
0.833
<0.001
<0.001
<0.001
0.001
0.839
0.545
0.336
0.059
0.142
0.007
0.605
0.010

Table 1 Characteristics of emergency medical admissions in development and validation datasets.

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Figure 1 Receiver Operating Characteristic curve for NEWS (left column) and NEWS2 (right column)
in predicting the risk of COVID-19 on admission for model M0/M0â€™, M1/M1â€™, and M2/M2â€™ in the
validation dataset

Note: predicted probability at NEWS (or NEWS2)
models.

threshold â‰¥5 (sensitivity, specificity) is shown for all

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

We assessed the performance of index NEWS/NEWS2 models to predict the risk of COVID-19 in
emergency medical admissions (see Table 2 and Figure 1). The c-statistics for predicting COVID-19
for Model M2â€™ is better than NEWS2 alone M0â€™ model in development (M0â€™=0.71; M1â€™=0.72, M2â€™:
0.78) and the validation dataset (M0â€™=0.65; M1â€™=0.67, M2â€™: 0.72). Moreover, the c-statistics for
predicting COVID-19 for NEWS2 models was similar to NEWS models in both, development and
validation datasets.

Model
M0
M1
M2
M0`
M1`
M2`

Mean Risk
Non-COVID

Mean Risk
COVID

ARD

0.11

0.14

0.03

0.01

0.11

0.14

0.04

0.02

0.10

0.18

0.08

0.05

0.11

0.14

0.03

0.00

0.11

0.14

0.04

0.01

0.10

0.19

0.09

0.06

Scaled Brier
Score

AUC (95% CIs)

Calibration Slope

0.65
(0.62 to 0.69)
0.67
(0.64 to 0.7)
0.72
(0.69 to 0.75)
0.65
(0.61 to 0.68)
0.67
(0.64 to 0.7)
0.72
(0.69 to 0.75)

0.72
(0.53 to 0.91)
0.81
(0.63 to 0.99)
0.78
(0.65 to 0.91)
0.69
(0.51 to 0.87)
0.78
(0.60 to 0.96)
0.76
(0.64 to 0.89)

Table 2: Performance of NEWS and NEWS2 models for predicting the risk of COVID on admission
for validation dataset
ARD: absolute risk difference; AUC: Area under the curve; CIs: confidence intervals

Table 3 includes the sensitivity, specificity, positive and negative predictive values for NEWS and
NEWS2 models for predicting COVID-19. NEWS2 models had higher sensitivity but lower specificity
compared to NEWS models because the predicted probability at NEWS2â‰¥5 (0.116) is smaller than at
NEWSâ‰¥5 (0.13).
Model M2â€™ had better calibration than Model M0â€™ (M2â€™: 0.78 (95%CI 0.65 vs 0.91) vs 0.69 (95%CI
0.51 to 0.87)) (see Table 2 & S4 and Figure 1 & S7) with improved sensitivity (M2â€™: 57% (95%CI 5163) vs M0â€™ 44% (95%CI 38-50)) and similar specificity (M2â€™: 76% (95%CI 74-78) vs M0â€™ 75% (95%CI
73-77)) for validation dataset at NEWS2â‰¥5 (see Table 3 & S5). Internal validation of these models is
shown in Figure S6. Figure 2 shows model calibration improved across the models and that models
M2â€™ and M2 are well-calibrated.

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Model M2â€™/M2 had highest clinical utility than Model M0â€™/M0 for validation datasets (see Figure 3)
and development dataset (see Figure S8). Nevertheless, NEWS/NEWS2 â‰¥5 is the worst performing
choice compared to the cNEWS models.

Figure 2 External validation of all NEWS (M0, M1, M2) and NEWS2 (M0â€™, M1â€™, M2â€™) models,
respectively for predicting the risk of COVID-19

NB: We limit the risk of COVID-19 to 0.30 for visualisation purpose because beyond this point, we
have few patients.

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Model

Number of
positive cases
identified by
model

M0

474

M1

600

M2

607

M0`

681

M1`

781

M2`

692

Sensitivity%

32.9
(27.4 to 38.7)
44
(38.1 to 50.1)
51.6
(45.6 to 57.6)
44.4
(38.5 to 50.5)
52.7
(46.6 to 58.7)
57
(51 to 62.9)

Specificity%

82.9
(81.3 to 84.5)
78.7
(76.9 to 80.4)
79.3
(77.6 to 81)
75.1
(73.3 to 76.9)
71.7
(69.8 to 73.5)
76.2
(74.4 to 77.9)

PPV

19.2
(15.7 to 23)
20.3
(17.2 to 23.8)
23.6
(20.2 to 27.1)
18.1
(15.2 to 21.2)
18.7
(16 to 21.6)
22.8
(19.8 to 26.1)

NPV

90.9
(89.6 to 92.1)
91.9
(90.6 to 93.1)
93
(91.8 to 94.1)
91.6
(90.3 to 92.9)
92.5
(91.1 to 93.7)
93.5
(92.3 to 94.6)

LR+

1.9
(1.6 to 2.3)
2.1
(1.8 to 2.4)
2.5
(2.2 to 2.9)
1.8
(1.5 to 2.1)
1.9
(1.6 to 2.1)
2.4
(2.1 to 2.7)

LR-

0.8
(0.7 to 0.9)
0.7
(0.6 to 0.8)
0.6
(0.5 to 0.7)
0.7
(0.7 to 0.8)
0.7
(0.6 to 0.7)
0.6
(0.5 to 0.6)

Table 3 Sensitivity analysis of three models for each NEWS and NEWS2 for predicting the risk of COVID at
threshold

â‰¥5 of NEWS (predicted probability of model M0 = 0.130) and NEWS2 (predicted probability of

model M0â€™ = 0.116) for validation dataset.

PPV=Positive Predictive Value; NPV= Negative Predictive Value; LR+=Positive Likelihood Ratio; LR-=Negative Likelihood Ratio

Figure 3 Net Benefit for model M0/M0â€™, M1/M1â€™, and M2/M2â€™ in predicting the risk of COVID-19
on admission in the validation dataset

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

Discussion

In this study, we developed and validated three computer-aided versions of NEWS/NEWS2 based
models which incorporated progressively more information. Model M0 uses NEWS alone; Model M1
extends M0 with age and sex; Model M2 extends M1 with all the subcomponents of NEWS plus
diastolic blood pressure. Equivalent models (M0â€™, M1â€™, M2â€™) were developed using NEWS2 (see
appendix for equations and escalation policy Figure S5).
NEWS2 models were more sensitive but less specific than NEWS models. Models M2 and M2â€™ were
the best in class, with the highest c-statistics (0.77 and 0.72 respectively). The high negative
predictive value suggests models M2 and M2â€™ may be particularly useful in ruling out COVID-19
early in the patients unplanned admission which is clinically useful because testing for COVID-19
using viral nucleic acid testing is time consuming.
A recent systematic review identified five models to detect COVID-19 infection in symptomatic
individuals with c-statistics that ranged from 0.87 to 1 (21). However, despite these high c-statistics,
the review authors cautioned against the use of these models in clinical practice because of the high
risk of bias and poor reporting of studies which are likely to have led to optimistic results (21).
The main advantages of our computer-aided NEWS2 models are that they are designed to
incorporate data which are already available in the patientâ€™s electronic health record and so place no
additional data collection or computational burden on clinicians and they are readily automated.
Nonetheless, we emphasize that our computer-aided risk scores are not designed to replace clinical
judgement. They are intended and designed to support, not subvert, the clinical decision-making
process and can be always overridden by clinical concern (5, 22). The working hypothesis for our
computer-aided NEWS scores is that they may enhance situational awareness of COVID-19 by
processing information already available without impeding the workflow of clinical staff, especially
as our approach offers a faster and less expensive assessment of COVID-19 risk than current
laboratory tests which may be more practical to use for large numbers of people.
There are limitations in relation to our study. We identified COVID-19 based on ICD-10 code â€˜U071â€™
which was determined by clinical judgment and/or swab test results and so our findings are
constrained by the accuracy of these methods (23, 24). We used the index NEWS or NEWS2 data in
our models, which reflects the â€œon-admissionâ€ risk of COVID-19 of the patient. Nonetheless, vital
signs are repeatedly updated for each patient according to hospital protocols. Although we
developed models using one hospital data and validated into other hospital data, the extent to
which changes in vital signs over time reflect changes in COVID-19 risk that need to be incorporated
in our models needs further study. While most of the studies reported insufficient sample size (25),

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

our study was sufficiently large for developing and validating relatively simple NEWS/NEWS2 based
prediction models(19). Our two hospitals are part of the same NHS Trust and this may undermine
the generalisability of our findings, which merit further external validation.
Furthermore, a crucial next phase of this work is to field test our models by carefully engineering
then into routine clinical practice (26, 27) to see if they do support the earlier detection and care of
COVID-19 in emergency medical patients without unintended adverse consequences.
Conclusion

Model M2â€™ is reasonably accurate for predicting the on-admission risk of COVID-19. It may be
clinically useful for an early warning system at the time of admission especially to triage large
numbers of unplanned hospital admissions.
Competing Interests

The authors declare no conflicts of interest. All authors have completed the(available on request
from the corresponding author) and declare: no support from any organisation for the submitted
work [other than the funders described below]; no financial relationships with any organisations that
might have an interest in the submitted work in the previous three years, no other relationships or
activities that could appear to have influenced the submitted work.
Funding

This research was supported by the Health Foundation. The Health Foundation is an independent
charity working to improve the quality of healthcare in the UK. This research was supported by the
National Institute for Health Research (NIHR) Yorkshire and Humber Patient Safety Translational
Research Centre (NIHR Yorkshire and Humber PSTRC). The views expressed in this article are those
of the author(s) and not necessarily those of the NHS, the Health Foundation, the NIHR, or the
Department of Health.
Role of the funding source

The funders of the study had no role in study design, data collection, data analysis, data
interpretation, or writing of the report.
Author contributions

DR and MAM had the original idea for the work. KB, RH provided the data extracts. MF undertook
the statistical analyses with support from MAM. MF, MAM, and DR wrote the first draft of the paper.
DR, SI and KS provided clinical perspectives. EW provided critical guidance and support. All others

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

contributed to the final paper and have approved the final version. DR & MF will act as study
guarantors.
Transparency declaration

The lead author (the manuscriptâ€™s guarantor) affirms that the manuscript is an honest, accurate, and
transparent account of the study being reported; that no important aspects of the study have been
omitted.
Ethical Approval

This study was deemed to be exempt from ethical approval because it was classified as an
evaluation. Furthermore, this study used already de-identified data from an ongoing study involving
NEWS which received ethical approval from Health Research Authority (HRA) and Health and Care
Research Wales (HCRW) (reference number 19/HRA/0548).
Patient involvement: none
Data sharing: our data sharing agreement is with York hospital and does not permit us to share the
data used in this paper.
References

1.
2.
3.
4.

5.
6.
7.

Gorbalenya AE, Baker SC, Baric RS, et al.: The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 [Internet]. Nat
Microbiol 2020; 5:536â€“544[cited 2020 Jun 24] Available from:
https://www.nature.com/articles/s41564-020-0695-z
Onder G, Rezza G, Brusaferro S: Case-Fatality Rate and Characteristics of Patients Dying in
Relation to COVID-19 in Italy [Internet]. JAMA - J Am Med Assoc 2020; 323:1775â€“1776[cited
2020 Jun 24] Available from: https://jamanetwork.com/journals/jama/fullarticle/2763667
Vincent JL, Taccone FS: Understanding pathways to death in patients with COVID-19
[Internet]. Lancet Respir Med 2020; 8:430â€“432[cited 2020 Jun 24] Available from:
http://www.thelancet.com/article/S221326002030165X/fulltext
Weekly statistics for NHS Test and Trace (England) and coronavirus testing (UK): 24
September to 30 September - GOV.UK [Internet]. [cited 2020 Oct 14] Available from:
https://www.gov.uk/government/publications/nhs-test-and-trace-england-and-coronavirustesting-uk-statistics-24-september-to-30-september-2020/weekly-statistics-for-nhs-test-andtrace-england-and-coronavirus-testing-uk-24-september-to-30-september
Royal College of Physicians: National Early Warning Score (NEWS): Standardising the
assessment of acuteillness severity in the NHS - Report of a working party. 2012;
NHS: Royal College of Physicians: NHS England approves use of National Early Warning Score
(NEWS) 2 to improve detection of acutely ill patients. [Internet]. 2017. Available from:
https://www.rcplondon.ac.uk/news/nhs-england-approves-use-national-early-warning-scorenews-2-improve-detection-acutely-ill
StatCorp: Stata: Release 14. Statistical Software. College Station, TX: StataCorp LP. 2016;

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.

Steyerberg EW: Clinical Prediction Models. A practical approach to development, validation
and updating. Springer; 2008.
Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating
characteristic (ROC) curve. Radiology 1982; 143:29â€“36
Robin X, Turck N, Hainard A, et al.: pROC: an open-source package for R and S+ to analyze and
compare ROC curves. BMC Bioinformatics 2011; 12:77
R Development Core Team: R: A language and environment for statistical computing. R
Foundation for Statistical Computing http://www.r-project.org/. 2015;
Steyerberg EW, Harrell FE, Borsboom GJJ., et al.: Internal validation of predictive models:
Efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001; 54:774â€“
781
Harrell FE: rms: Regression Modeling Strategies http://cran.r-project.org/package=rms. 2015;
National Institute for Health and Care Excellence. Sepsis Quality Standard [QS161]. Published
September 2017 [Internet]. Available from:
https://www.nice.org.uk/guidance/qs161/resources/sepsis-pdf-75545595402181
NHS England. Sepsis Guidance implementation advice for adults: NHS England, Sept 17
[Internet]. Available from: https://www.england.nhs.uk/wpcontent/uploads/2017/09/sepsis-guidance-implementation-advice-for-adults.pdf
Sing T, Sander O, Beerenwinkel N, et al.: ROCR: visualizing classifier performance in R.
Bioinformatics 2005; 21:3940â€“3941
Vickers AJ, Elkin EB: Decision curve analysis: a novel method for evaluating prediction models.
[Internet]. Med Decis Making 2006; 26:565â€“74[cited 2016 Jun 3] Available from:
http://mdm.sagepub.com/content/26/6/565.short
CRAN - Package pmsampsize [Internet]. [cited 2020 Aug 3] Available from: https://cran.rproject.org/web/packages/pmsampsize/index.html
Riley RD, Ensor J, Snell KIE, et al.: Calculating the sample size required for developing a clinical
prediction model. BMJ 2020; 368
Moons KGM, Altman DG, Reitsma JB, et al.: Transparent Reporting of a multivariable
prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
[Internet]. Ann Intern Med 2015; 162:W1[cited 2018 Jun 26] Available from:
http://annals.org/article.aspx?doi=10.7326/M14-0698
Wynants L, Van Calster B, Collins GS, et al.: Prediction models for diagnosis and prognosis of
covid-19: Systematic review and critical appraisal [Internet]. BMJ 2020; 369:18[cited 2020
Aug 3] Available from: https://www.bmj.com/content/369/bmj.m1328
Balamuth F, Alpern ER, Abbadessa MK, et al.: Improving Recognition of Pediatric Severe
Sepsis in the Emergency Department: Contributions of a Vital Sign-Based Electronic Alert and
Bedside Clinician Identification. Ann Emerg Med 2017; 70:759-768.e2
Corfield AR, Lees F, Zealley I, et al.: Utility of a single early warning score in patients with
sepsis in the emergency department. 2012;
Churpek MM, Snyder A, Han X, et al.: Quick Sepsis-related Organ Failure Assessment,
Systemic Inflammatory Response Syndrome, and Early Warning Scores for Detecting Clinical
Deterioration in Infected Patients outside the Intensive Care Unit. Am J Respir Crit Care Med
2017; 195:906â€“911
Sperrin M, Grant SW, Peek N: Prediction models for diagnosis and prognosis in Covid-19. BMJ
2020; 369

medRxiv preprint doi: https://doi.org/10.1101/2020.11.30.20241257; this version posted December 2, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
All rights reserved. No reuse allowed without permission.

26. Escobar GJ, Dellinger RP: Early detection, prevention, and mitigation of critical illness outside
intensive care settings. J Hosp Med 2016; 11:S5â€“S10
27. Escobar GJ, Turk BJ, Ragins A, et al.: Piloting electronic medical record-based early detection
of inpatient deterioration in community hospitals. J Hosp Med 2016; 11:S18â€“S24

